(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...
LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose ...
Everyday Health on MSN
The 16 best sunscreens for all budgets and skin types in 2026, tested and expert-vetted
From mineral formulas that won’t leave a white cast to lightweight options for oily skin, these 16 sunscreens stood out in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results